Intensive blood pressure lowering has substantial benefits for both the prevention and treatment of malignant left ventricular hypertrophy, a new analysis of the SPRINT trial shows.

In women, HF with T2DM has a relative risk of 1.95 and contributes to cardiac remodeling and LVH, possibly through oxidative stress.3,7 LVH may be brought about by insulin resistance, decreased ...

It is often a reversible process that does not cause serious effects on the structure or function of the heart, but if the factor causing cardiac overload becomes chronic, it can lead to ...

T-wave3 T-waves represent the recovery period following ventricular depolarization and contraction (referred to as “repolarization”). Normally upright in leads I, II, and V3-V6.

Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac disease marked by left ventricular hypertrophy, often due to sarcomere gene mutations. Using transcriptomic, DNA methylomic, and ...

Objectives American-style football (ASF) athletes are at risk for the development of concentric left ventricular hypertrophy (C-LVH), an established cardiovascular risk factor in the general ...

Left ventricular noncompaction is characterized by deep trabeculations in the LV endocardium in association with left ventricular hypertrophy, dilation or hypertrophy/dilation. Noncompaction of the ...

The research presented in the article delves into the regulatory role of the long non-coding RNA (lncRNA) ZNF593-AS in cardiac hypertrophy and myocardial remodeling, processes that are pivotal in ...

In preclinical studies, TN-201 showed significant reversal of left ventricular hypertrophy, cardiac dysfunction, and electrophysiological deficits in a severe murine model, which was dose ...